DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers
Authors
Keywords
-
Journal
JOURNAL OF MAGNETIC RESONANCE IMAGING
Volume 48, Issue 1, Pages 237-247
Publisher
Wiley
Online
2017-12-08
DOI
10.1002/jmri.25921
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?
- (2017) Michael R. Harowicz et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Computer-aided heterogeneity analysis in breast MR imaging assessment of ductal carcinoma in situ: Correlating histologic grade and receptor status
- (2017) Shinn-Huey S. Chou et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer
- (2017) Ming Fan et al. PLoS One
- Breast cancer molecular subtype classifier that incorporates MRI features
- (2016) Elizabeth J. Sutton et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status
- (2016) Jong Ki Shin et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Intratumor partitioning and texture analysis of dynamic contrast-enhanced (DCE)-MRI identifies relevant tumor subregions to predict pathological response of breast cancer to neoadjuvant chemotherapy
- (2016) Jia Wu et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI
- (2016) Ruey-Feng Chang et al. MAGNETIC RESONANCE IMAGING
- A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk Scores
- (2016) Tao Wan et al. Scientific Reports
- Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay
- (2015) Elizabeth J. Sutton et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Heterogeneity in intratumoral regions with rapid gadolinium washout correlates with estrogen receptor status and nodal metastasis
- (2015) Baishali Chaudhury et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes
- (2015) Eric Blaschke et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Breast DCE-MRI Kinetic Heterogeneity Tumor Markers: Preliminary Associations With Neoadjuvant Chemotherapy Response
- (2015) Ahmed Ashraf et al. Translational Oncology
- Parameters of Dynamic Contrast-Enhanced MRI as Imaging Markers for Angiogenesis and Proliferation in Human Breast Cancer
- (2015) Baozhong Shen MEDICAL SCIENCE MONITOR
- Ki-67 as a Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
- (2014) Kwan Il Kim et al. Journal of Breast Cancer
- Radiogenomic Analysis of Breast Cancer: Luminal B Molecular Subtype Is Associated with Enhancement Dynamics at MR Imaging
- (2014) Maciej A. Mazurowski et al. RADIOLOGY
- Intratumoral heterogeneity of the distribution of kinetic parameters in breast cancer: comparison based on the molecular subtypes of invasive breast cancer
- (2014) Ken Yamaguchi et al. Breast Cancer
- Treatment of Estrogen Receptor-Positive Breast Cancer
- (2013) F. Lumachi et al. CURRENT MEDICINAL CHEMISTRY
- Computer-Aided Diagnosis of Breast DCE-MRI Images Using Bilateral Asymmetry of Contrast Enhancement Between Two Breasts
- (2013) Qian Yang et al. JOURNAL OF DIGITAL IMAGING
- Quantitative assessment Ki-67 score for prediction of response to neoadjuvant chemotherapy in breast cancer
- (2013) Jason R Brown et al. LABORATORY INVESTIGATION
- Background Parenchymal Signal Enhancement Ratio at Preoperative MR Imaging: Association with Subsequent Local Recurrence in Patients with Ductal Carcinoma in Situ after Breast Conservation Surgery
- (2013) Sun-Ah Kim et al. RADIOLOGY
- Developments in Ki67 and other biomarkers for treatment decision making in breast cancer
- (2012) A. Sheri et al. ANNALS OF ONCOLOGY
- Intratumor Heterogeneity: Evolution through Space and Time
- (2012) C. Swanton CANCER RESEARCH
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- pROC: an open-source package for R and S+ to analyze and compare ROC curves
- (2011) Xavier Robin et al. BMC BIOINFORMATICS
- Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
- (2011) Peter A Fasching et al. BMC CANCER
- Heterogeneity in breast cancer
- (2011) Kornelia Polyak JOURNAL OF CLINICAL INVESTIGATION
- Assessing heterogeneity of lesion enhancement kinetics in dynamic contrast-enhanced MRI for breast cancer diagnosis
- (2010) A Karahaliou et al. BRITISH JOURNAL OF RADIOLOGY
- Ki67 in breast cancer: prognostic and predictive potential
- (2010) Rinat Yerushalmi et al. LANCET ONCOLOGY
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. Journal of Oncology Practice
- Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients
- (2008) R. Stuart-Harris et al. BREAST
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started